anmelden
OMX Copenhagen PI
1.348,92
PKT
+4,30
PKT
+0,32
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Copenhagen PI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.09.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.09.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 04.09.23 | Novo Nordisk Overweight | Barclays Capital | |
| 30.08.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 21.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 15.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 11.08.23 | Novo Nordisk Sell | UBS AG | |
| 11.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 10.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.08.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 09.08.23 | Novo Nordisk Sell | UBS AG | |
| 08.08.23 | Novo Nordisk Overweight | Barclays Capital | |
| 08.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.08.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 07.08.23 | A.P. Moeller - Maersk A-S (B) Overweight | JP Morgan Chase & Co. | |
| 07.08.23 | A.P. Moeller - Maersk A-S (B) Sell | Goldman Sachs Group Inc. | |
| 03.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.07.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 13.07.23 | A.P. Moeller - Maersk A-S (B) Buy | UBS AG | |
| 12.07.23 | Novo Nordisk Sell | UBS AG | |
| 12.07.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.07.23 | Novo Nordisk Outperform | Credit Suisse Group | |
| 05.07.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 03.07.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.06.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 28.06.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 27.06.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 26.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 26.06.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 26.06.23 | Novo Nordisk Sell | UBS AG | |
| 20.06.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.06.23 | Novo Nordisk Sell | UBS AG | |
| 15.06.23 | A.P. Moeller - Maersk A-S (B) Overweight | JP Morgan Chase & Co. | |
| 12.06.23 | Novo Nordisk Sell | UBS AG |
